Literature DB >> 15793290

The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis.

Liv Eidsmo1, Susanne Nylen, Ali Khamesipour, Mari-Anne Hedblad, Francesca Chiodi, Hannah Akuffo.   

Abstract

Cutaneous leishmaniasis (CL), caused by the intracellular protozoan Leishmania major, is characterized by lesion formation and ulceration at the site of infection. The mechanism of ulcer formation during CL is not fully understood. The expression of Fas and FasL and the levels of apoptosis in skin biopsies and in restimulated blood mononuclear cells from patients with 1 to 7 months of L. major-induced CL were analyzed using immunohistochemistry and fluorescence-activated cell sorting analysis. The levels of soluble Fas and FasL were also analyzed by enzyme-linked immunosorbent assay. A substantial number of apoptotic keratinocytes were observed mainly in the superficial epidermis of morphologically active and healing CL skin samples. Fas expression was increased on epidermis in active CL, whereas Fas expression was similar in healing and healthy epidermis. FasL-expressing macrophages and T cells were found in subepidermal infiltrate, mainly in active disease. When CL peripheral blood mononuclear cells were restimulated with L. major, Fas was up-regulated on effector T cells, and high levels of sFasL were secreted. Supernatants from restimulated cultures induced apoptosis in human keratinocytes (HaCaT), possibly through Fas/FasL interactions. Our results indicate that FasL-expressing effector T cells and macrophages may act to induce apoptosis and ulcer formation in Fas-expressing keratinocytes during L. major infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793290      PMCID: PMC1602394          DOI: 10.1016/S0002-9440(10)62330-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies.

Authors:  J Sträter; H Walczak; C Hasel; I Melzner; F Leithäuser; P Möller
Journal:  Cell Death Differ       Date:  2001-03       Impact factor: 15.828

Review 2.  Programmed cell death in trypanosomatids and other unicellular organisms.

Authors:  Alain Debrabant; Nancy Lee; Sylvie Bertholet; Robert Duncan; Hira L Nakhasi
Journal:  Int J Parasitol       Date:  2003-03       Impact factor: 3.981

3.  Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand.

Authors:  Tracy Vargo-Gogola; Howard C Crawford; Barbara Fingleton; Lynn M Matrisian
Journal:  Arch Biochem Biophys       Date:  2002-12-15       Impact factor: 4.013

4.  Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience.

Authors:  M Stella; P Cassano; D Bollero; A Clemente; G Giorio
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

5.  Mechanisms of apoptosis in murine fibroblasts by two intracellular protozoan parasites, Toxoplasma gondii and Neospora caninum.

Authors:  Yoshifumi Nishikawa; Levi Makala; Haruki Otsuka; Takeshi Mikami; Hideyuki Nagasawa
Journal:  Parasite Immunol       Date:  2002-07       Impact factor: 2.280

6.  Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.

Authors:  Nicolas Bachot; Jean Revuz; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2003-01

7.  Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases.

Authors:  Christa Prins; Francisco A Kerdel; R Steven Padilla; Thomas Hunziker; Sergio Chimenti; Isabelle Viard; Davide N Mauri; Kirsten Flynn; Jennifer Trent; David J Margolis; Jean-Hilaire Saurat; Lars E French
Journal:  Arch Dermatol       Date:  2003-01

8.  Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience.

Authors:  Jennifer T Trent; Robert S Kirsner; Paolo Romanelli; Francisco A Kerdel
Journal:  Arch Dermatol       Date:  2003-01

9.  Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major.

Authors:  Eresso Aga; Dörthe M Katschinski; Ger van Zandbergen; Helmut Laufs; Birgit Hansen; Kerstin Müller; Werner Solbach; Tamás Laskay
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

10.  Alteration of Fas and Fas ligand expression during human visceral leishmaniasis.

Authors:  L Eidsmo; D Wolday; N Berhe; F Sabri; I Satti; A M El Hassan; S Sundar; F Chiodi; H Akuffo
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

View more
  10 in total

1.  FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.

Authors:  Liv Eidsmo; Caroline Fluur; Bence Rethi; Sofia Eriksson Ygberg; Nicolas Ruffin; Angelo De Milito; Hannah Akuffo; Francesca Chiodi
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Inhibition of caspase-8 activity promotes protective Th1- and Th2-mediated immunity to Leishmania major infection.

Authors:  Wânia F Pereira-Manfro; Flávia L Ribeiro-Gomes; Alessandra Almeida Filardy; Natália S Vellozo; Landi V C Guillermo; Elisabeth M Silva; Richard M Siegel; George A Dosreis; Marcela F Lopes
Journal:  J Leukoc Biol       Date:  2013-09-26       Impact factor: 4.962

3.  Activity of synthetic chalcones in hamsters experimentally infected with Leishmania (Viannia) braziliensis.

Authors:  Tatiane F P de Mello; Bruna M Cardoso; Sara N Lopes; Heriberto R Bitencourt; Evandra M Voltarelli; Luzmarina Hernandes; Sandra M A Aristides; Maria V C Lonardoni; Thais G V Silveira
Journal:  Parasitol Res       Date:  2015-06-23       Impact factor: 2.289

4.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

5.  Apoptosis induced by parasitic diseases.

Authors:  Anne-Lise Bienvenu; Elena Gonzalez-Rey; Stephane Picot
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

6.  Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

Authors:  Geremew Tasew; Susanne Nylén; Thorsten Lieke; Befekadu Lemu; Hailu Meless; Nicolas Ruffin; Dawit Wolday; Abraham Asseffa; Hideo Yagita; Sven Britton; Hannah Akuffo; Francesca Chiodi; Liv Eidsmo
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

Review 7.  Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis.

Authors:  Albert Schriefer; Mary E Wilson; Edgar M Carvalho
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

8.  FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control.

Authors:  Bence Rethi; Liv Eidsmo
Journal:  Front Immunol       Date:  2012-06-19       Impact factor: 7.561

Review 9.  The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection.

Authors:  Katiuska Passelli; Oaklyne Billion; Fabienne Tacchini-Cottier
Journal:  Front Immunol       Date:  2021-03-01       Impact factor: 7.561

10.  Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease.

Authors:  Andrew Kovalenko; Jin-Chul Kim; Tae-Bong Kang; Akhil Rajput; Konstantin Bogdanov; Oliver Dittrich-Breiholz; Michael Kracht; Ori Brenner; David Wallach
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.